Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Journal

Definitions

1
h-index
6
Citations
11
Works

Trust signals

0 of 3 signals present

Independent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.

  • DOAJ
    No data
    doaj.org
  • OAK list
    No data
    OAK
  • Valid ISSN
    No data
    ISSN

This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.

Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
051015200122012202020212022202420252012: Publications 0, Citations 12020: Publications 11, Citations 02021: Publications 0, Citations 22022: Publications 0, Citations 12024: Publications 0, Citations 12025: Publications 0, Citations 1

Citation history

0122012202020212022202420252012: Citations 12020: Citations 02021: Citations 22022: Citations 12024: Citations 12025: Citations 1

Publication history

051015202012202020212022202420252012: Publications 02020: Publications 112021: Publications 02022: Publications 02024: Publications 02025: Publications 0

h-index evolution

Cumulative h-index by year

01202020212022202420252020: h-index 12021: h-index 12022: h-index 12024: h-index 12025: h-index 1

Most-cited works

  1. International Agency for Research on Cancer20206 citations
  2. Flanvotumab20200 citations
  3. Anetumab20200 citations
  4. Narnatumab20200 citations
  5. Catumaxomab20200 citations
  6. Ombitasvir20200 citations
  7. Gerbil Fibrosarcoma20200 citations
  8. Anetumab Ravtansine20200 citations
  9. Ustilago maydis20200 citations
  10. Seribantumab20200 citations
View in AkademIndex →